Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NAFTIFINE HCL 2% CREAM

Naftifine Hydrochloride
$1.9779per GM

Strength

20 mg/g

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

51672136806

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

NAFTIFINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206901

On Market Since

1/6/2016

Pharmacological Classes

Allylamine Antifungal
Allylamine

Price History

1W

0.0%

1M

-6.1%

3M

-11.5%

6M

-10.1%

1Y

-16.4%

3Y

-47.5%

5Y

-52.3%

All

-72.1%

Generic Alternatives

1 alternative • Same active ingredient

NAFTIFINE HCL 2% CREAM
Generic
51672136803•Sun Pharmaceutical Industries Inc.
$2.1159
+7% more

Related Drugs

Same classification

TERBINAFINE HCL 250 MG TABLET
Generic
16714079501•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
16714079502•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
51991052601•Breckenridge Pharmaceutical Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057230•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057290•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
65862007930•Aurobindo Pharma Limited
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085902•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085907•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035113•Bionpharma Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035120•Bionpharma Inc.
$0.1409
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy